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transiently increased. After the Pringle maneuver alone, 
purine plasma concentrations were most increased. This 
strong rise in plasma purines caused by the Pringle ma-
neuver, however, was signifi cantly attenuated by IPC. 
When portal venous minus arterial concentration differ-
ence was calculated for inosine or hypoxanthine, the re-
spective differences became positive in patients subject-
ed to the Pringle maneuver and were completely 
prevented by preconditioning.  Conclusion: These data 
demonstrate that (i) IPC increases formation of adeno-
sine, and that (ii) the unwanted degradation of adenine 
nucleotides to purines caused by the Pringle maneuver 
can be attenuated by IPC. Because IPC also induces a 
decrease of portal venous minus arterial purine plasma 
concentration differences, IPC might possibly decrease 
disturbances in the energy metabolism in the intestine 
as well. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 Ischemic preconditioning (IPC) has been shown to be 
a powerful protective measure in different hepatic models 
of warm  [1] and cold  [2] ischemia-reperfusion injury. Al-
though protection from ischemic injury by ischemic pre-
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 Abstract 
 Background/Aims: Degradation of adenine nucleotides 
to adenosine has been suggested to play a critical role 
in ischemic preconditioning (IPC). Thus, we questioned 
in patients undergoing partial hepatectomy whether 
(i) IPC will increase plasma purine catabolites and wheth-
er (ii) formation of purines in response to vascular clamp-
ing (Pringle maneuver) can be attenuated by prior IPC. 
 Methods: 75 patients were randomly assigned to three 
groups: group I underwent hepatectomy without vascu-
lar clamping; group II was subjected to the Pringle ma-
neuver during resection, and group III was precondi-
tioned (10 min ischemia and 10 min reperfusion) prior to 
the Pringle maneuver for resection. Central, portal ve-
nous and arterial plasma concentrations of adenosine, 
inosine, hypoxanthine and xanthine were determined by 
high-performance liquid chromatography.  Results: Du-
ration of the Pringle maneuver did not differ between 
patients with or without IPC. Surgery without vascular 
clamping had only a minor effect on plasma purine con-
centrations. After IPC, plasma concentrations of purines 
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conditiong is well documented, the underlying mecha-
nisms have not been identifi ed so far. Among many oth-
ers (catecholamines, kinins, opioids, eicosanoids and 
nitric oxide (NO)), adenosine has been suggested to be a 
central mediator in hepatic preconditioning  [3] . Even 
short periods of ischemia cause the enhanced breakdown 
of adenine nucleotides to adenosine (fi g. 1). Although hy-
poxia predominantly results in the degradation of intra-
cellular adenine nucleotides, adenine nucleotides can also 
be released into the extracellular space via specifi c trans-
porters or e.g. by the reperfusion-induced damage of cell 
membranes. In the extracellular space, adenosine triphos-
phate (ATP) is rapidly hydrolyzed by a cascade of ecto-
nucleotidases to generate adenosine and its degradation 
product inosine again. Both intracellular and extracellu-
lar adenosine are in steady state across the cell membrane 
via high- and low-capacity nucleoside transporters. 
 Irrespective of its sites of generation, adenosine can 
bind to extracellular specifi c receptors. Acting via A 2  re-
ceptors on hepatocytes  [3] and sinusoidal endothelial cells 
 [2] , adenosine was suggested to increase the formation of 
NO as a more downstream located mediator of IPC  [1] . 
The half-life of adenosine in plasma, which is similar to 
NO, is very short. This half-life is  ! 2 s at its concentration 
in the normal range (up to 150 n M )  [4] . 
 Under physiological conditions, removal of adenosine 
from plasma occurs via the uptake by erythrocytes and 
vascular endothelial cells through the aforementioned 
high- and low-capacity nucleoside transporters. 
 Under pathological conditions, e.g. hypoxia, adeno-
sine is predominantly degraded by the enzyme adenosine 
deaminase to inosine. Since adenosine deaminase is also 
present in the plasma, deamination of adenosine to ino-
sine there also occurs. Like adenosine, extracellular ino-
sine can be taken up by cells through the transmembran-
al nucleoside transporters. Together with the inosine al-
ready formed in the cell, inosine is further degraded to 
hypoxanthine and the latter to xanthine. Thus, in addi-
tion to direct determination of adenosine, measurement 
of the purine metabolites inosine, hypoxanthine and xan-
thine indirectly refl ects its formation and approximately 
equals the degradation of high-energy adenine nucleo-
tides during hepatic ischemia. 
 Regarding the pathophysiological role of purines dur-
ing ischemia-reperfusion, we hypothesized that (i) IPC 
will induce formation of adenosine and (ii) IPC will at-
tenuate adverse metabolic effects caused by prolonged 
periods of ischemia (e.g. Pringle maneuver for liver resec-
tion). Accordingly, we questioned in patients undergoing 
partial hepatectomy (i) whether even a brief period of IPC 
will be suffi cient to cause a transient increase of plasma 
purines, especially of hepato-protective adenosine and 
(ii) whether the Pringle maneuver induced unwanted deg-
radation of adenine nucleotides to purines can be attenu-
ated by IPC. 
 Material and Methods 
 Study Design and Randomization 
 The study protocol was approved in accordance with the guide-
lines of the 1975 Declaration of Helsinki by the Ethics Committee 
of Ludwig Maximilians University of Munich and written in-
formed consent was obtained from each patient before surgery. 100 
patients were tested for eligibility from March 1999 to August 2000. 
One subject was excluded from randomization, because he did not 
meet the inclusion criteria which were: (1) an American Society of 
Anesthesiologists’ Physical Status (ASA-PS) – classifi cation score 4 
or 5; (2) other than hepatic tumor was diagnosed unexpectedly be-
fore surgery; (3) severe liver steatosis or cirrhosis was assumed pri-
or to surgery, and (4) when patient’s age was  ! 18 years. After enrol-
ment and evaluation by the participating physicians, the patients 
were assigned by lot to one of the three study groups. For that pur-
pose, three lots were labeled with NPR, PR and IPC, were folded 
thereafter and then placed into a bowl. One lot was taken out of 
three. For the next patient the same procedure was repeated with 
three new lots. Hence, a total of 99 patients were allocated to NPR 
(n = 28) to PR (n = 33) and to IPC (n = 38). Intraoperatively, a few 
patients could not receive the procedure which was designated by 
lot, because of surgical reasons. Therefore, 2 patients from the NPR 
group were cross-allocated to the PR group, while 3 patients from 
the PR group and 2 patients from the IPC group were cross-allo-
cated to the NPR group. In addition, patients had to be excluded 
intraoperatively for reasons of drug administration (anti-infl amma-
tory drugs, e.g. pentoxfylline, corticosteroids) or when a liver cir-
rhosis was intraoperatively identifi ed. Moreover, other surgical rea-
ATP ADO XINO HXADP AMP
ATP ADO XINO HXADP AMP
Intracellular
Extracellular
 Fig. 1. Adenine nucleotides and nucleoside-related intracellular 
and extracellular exchange and metabolic pathways. ATP = 
 Adenosine triphosphate; ADP = adenosine diphosphate; AMP = 
adenosine monophosphate; ADO = adenosine; INO = inosine; 
HX = hypoxanthine; X = xanthine [22].
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sons (inoperability, massive hemorrhage, additional surgical pro-
cedures, e.g. bilio-enteric anastomosis) led to further dropouts. 
Thus, of 99 patients randomly assigned to three study groups, 25 
patients in each group underwent elective major hepatectomy (for 
further details also referring to CONSORT criteria, see Choukèr et 
al.  [16] ). Because of diffi cult blood collection from the portal vein 
and the loss of a few samples due to inappropriate handling, the 
number of specimens available for analyses was smaller than 25 per 
group. 
 In group I, partial hepatectomy was performed without vascular 
clamping of the portal triad (Pringle maneuver). In group II, pa-
tients were subjected to the Pringle maneuver during parenchymal 
resection. In group III, livers of patients were preconditioned by a 
brief period of 10 min of ischemia followed by 10 min of reperfu-
sion prior to the Pringle maneuver. 
 Anesthesia and Surgery 
 All operations were performed under general anesthesia (thio-
pental,  cis -atracurium, fentanyl, desfl urane 5–6 vol%) in combina-
tion with epidural anesthesia according to a standardized protocol. 
Body temperature was kept between  36.0 and 37.0  °  C by continu-
ous warming with a convective air-warming system. 
 All patients underwent laparotomy. For right hemihepatecto-
mies the liver was mobilized to expose the inferior vena cava and 
the short caudate veins were ligated and divided before portal triad 
clamping. Similarly, hepatic veins were isolated, but not ligated 
prior to the IPC or Pringle maneuver. Clamping of the portal triad 
was performed without affecting the bile duct. Transection was 
started immediately after inducing the Pringle maneuver which 
was maintained until the transection was fi nished. Parenchymal 
transection was performed by use of a water jet cutter (Saphir Med-
ical ,  Lyon ,  France)  [6] . The volume of the resected liver was deter-
mined by the quantity of displaced fl uid in a prefi lled trough. Op-
erations were performed by staff surgeons. 
 Plasma Concentrations of Purines and Lactate 
 Central venous and arterial blood samples were drawn through 
indwelling catheters. Insertion of central venous catheters was con-
trolled by ECG tracing in order to place tips of catheters in the right 
atrium. Portal venous blood samples were drawn intraoperatively 
by direct puncture of the portal vein. Plasma concentrations of pu-
rine nucleosides (adenosine and inosine) were analyzed by dual 
column switching high-affi nity performance/reversed-phase high-
performance liquid chromatography technique using an internal 
surface nitrophenylboronic acid precolumn as previously described 
 [7] . Purine bases (hypoxanthine and xanthine) were determined by 
reversed-phase high-performance liquid chromatography by a 
modifi ed method published previously  [8] . Plasma lactate concen-
trations were amperiometrically determined by the lactase oxidase 
catalyzed oxidation reaction using a blood gas analyzer (ABL 700, 
Radiometer, Copenhagen, Denmark). 
 Hepatocellular Function 
 Postoperative liver function and hepatocellular integrity were 
monitored by routine laboratory parameters. 
 Statistical Analyses 
 Calculation of Sample Size 
 Since hepatic protection by IPC has to be shown by its effects 
on serum liver enzyme activities, is likely to refl ect protection at 
the metabolic level as well, estimation of sample size was based on 
the endpoint ‘reduction of serum liver enzyme activities’. Assum-
ing that IPC reduces amino alanine and aspartate aminotransferase 
(ALT, AST) serum enzyme activities to levels of 33% of the isch-
emic control group and assuming a fi rst and second type error of 5 
and 10%, the number of patients was calculated to 25 per group 
 [5] . 
 Intra- and Intergroup Statistical Comparisons 
 Demographic data and surgery-related data were normally dis-
tributed (one-sample Kolmogorov-Smirnov) and hence tested by 
ANOVA and post-hoc unpaired t test for detection of intergroup 
differences. Testing for differences in ratios of females to males 
between groups was performed by    2 -test. Since the other variables 
were frequently not normally distributed, parameter-free tests were 
applied. Multiple comparisons within groups were performed by 
the Friedman test and post-hoc Wilcoxon test. Comparison of data 
between groups was done by Kruskal-Wallis test and post-hoc 
Mann-Whitney U-test. 
 Since the authors decided not to apply Bonferroni correction 
despite multiple testing, it should be recognized that this decision 
could limit the strength of the interpretation and make it necessary 
to consider marginal fi ndings as completely preliminary. Although 
type I error could have been reduced by Bonferroni correction, cor-
rection by this method would have increased a type II error. Since 
in the latter case a biological or a clinical relevant effect of IPC that 
truly exists would not be recognized, our study would fail to allow 
identifi cation of conditions that are worthwhile analyzing in more 
detail in future studies. All statistical procedures were two-tailed 
and a p value  ! 0.05 was considered statistically signifi cant. Analy-
ses were performed by SPSS statistical program (SPSS/PC+ Ver-
sion 10, SPSS Inc., Chicago, Ill., USA). 
 Results 
 Patients’ Characteristics and Intraoperative Data 
 Demographic data and intraoperative parameters did 
not signifi cantly differ between patient groups. In par-
ticular, there was no difference between groups with re-
spect to the duration of resection, the Pringle maneuver, 
and the volume of resected liver  [16] . 
 Plasma Concentrations of Adenosine and Its 
Catabolites before and after Preconditioning 
 Plasma concentrations of adenosine determined be-
fore preconditioning in central venous, arterial and portal 
venous blood were not signifi cantly different from each 
other. Early after the start of reperfusion ( ! 90 s), adeno-
sine plasma concentrations increased in portal venous 
blood but did not reach the level of statistical signifi cance. 
However, the elevation of adenosine plasma concentra-
tions was paralleled by a more pronounced increase of its 
metabolites inosine, hypoxanthine and xanthine ( fi g. 2 ). 
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 Plasma Concentrations of Lactate before and after 
Preconditioning 
 Plasma lactate concentrations increased from 1.10  8 
0.07 to 1.76  8 0.10 mmol/l in central venous blood 
(means  8 SEM, n = 25; p  ! 0.05) and from 1.09  8 0.07 
to 1.86  8 0.11 mmol/l in portal venous blood (means  8 
SEM, n = 25; p  ! 0.05). 
 Plasma Concentrations of Purines before and after 
the Pringle Maneuver 
 Following 10 min of ischemia and an additional pe-
riod of 10 min of reperfusion, plasma concentrations of 
inosine, hypoxanthine and xanthine were returned to 
normal levels ( fi g. 3 time point ‘Pre’). Thus, plasma con-
centrations of purine nucleosides and bases of patients 
previously preconditioned were not signifi cantly differ-
ent from those determined in patients of the other groups. 
After partial hepatectomy in the absence of the Pringle 
maneuver (control group I), no signifi cant changes of all 
three types of plasma purines occurred with the exception 
of hypoxanthine determined in arterial and portal venous 
blood. 
 In contrast to control group I, group II patients who 
were subjected to the Pringle maneuver during partial 
hepatectomy exhibited a strong increase of all purines at 
all sampling sites with the highest values being observed 
3 min after start of reperfusion. 
 The rise of purine plasma concentrations caused by 
the Pringle maneuver was decreased at all sampling sites 
in patients who had previously undergone precondition-
ing (group III). The attenuation of purine plasma concen-
trations by IPC was most pronounced during early reper-
fusion (3 and 15 min) and was statistically signifi cant 
different between groups II and III for inosine and hypo-
xanthine in portal venous blood. 
 With respect to the plasma concentrations of adeno-
sine, no changes were observed in patients of the control 
group. In group II patients only a slight rise occurred dur-
ing early reperfusion. These effects, however, did not 
reach the level of statistical signifi cance (data not 
shown). 
 Calculated Differences: Portal Venous minus Arterial 
Purine Plasma Concentration 
 In order to estimate formation of purines in the intes-
tine, purine plasma concentration determined in arterial 
blood was subtracted from the concentration measured 
in portal venous blood specimens taken simultaneously. 
There were no differences between groups prior to the 
start of the Pringle maneuver or partial hepatectomy with 
respect to all types of purines studied ( table 1 ). Upon re-
perfusion the portal venous minus arterial plasma con-
centration differences became positive for inosine and 
hypoxanthine only in patients of group II, with the dif-
ference for hypoxanthine being signifi cantly lower in pa-
tients previously preconditioned (group III). 
 Plasma Lactate Concentrations 
 IPC caused an elevation in plasma lactate concentra-
tions (see also section ‘Plasma Concentrations of Lactate 
Before  and  After Preconditioning’). Although another 
10-min period of reperfusion had passed after IPC until 
the next blood samples were taken for determination of 
baseline ‘Pre resection’ plasma lactate concentrations, 
there was still a signifi cant difference between groups II 
 Fig. 2. Central venous (Cv), arterial (Art), and portal venous (Pv) 
plasma concentrations of adenosine, inosine hypoxanthine and 
xanthine before (  g ) and after (  i ) IPC. Ischemic preconditioning 
was performed by 10 min of portal triad clamping followed by 
10 min of reperfusion. Concentrations shown were determined at 
the respective sites within the fi rst 90 s of reperfusion. Means  8 
SEM, n = 21–23, * p  ! 0.05 vs. before preconditioning, Wilcoxon 
test.
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 Fig. 3. Central venous (Cv), arterial (Art), and portal venous (Pv) 
plasma concentrations of inosine, hypoxanthine and xanthine be-
fore and after partial hepatectomy without clamping of the portal 
triad (group I,  g ), with clamping of the portal triad, i.e. Pringle 
maneuver (group II,  i ) and with the Pringle maneuver preceded 
by IPC (group III, k). Pre: before start of the Pringle maneuver or 
partial hepatectomy. 3, 15, 30: time in minutes after start of re-
perfusion. Means  8 SEM, n = 16–23, * p  ! 0.05 vs. Pre, Friedman 
and post-hoc Wilcoxon test;  #  p  ! 0.05 vs. group I,  §  vs. group III, 
Kruskal-Wallis test and post-hoc Mann-Whitney test. 
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and III in central venous lactate concentrations prior to 
the start of the Pringle maneuver (see  table 2:  ‘Pre resec-
tion’). After the end of the Pringle maneuver, plasma 
concentrations of lactate increased further in both groups. 
The values determined during reperfusion were reduced 
by IPC but were not statistically signifi cant. However, 
when the absolute rise in the plasma concentrations be-
tween Pre resection and 3 min after the Pringle maneu-
ver was calculated (see  table 2 : 3 min minus Pre values) 
and compared between both groups, the absolute con-
centration changes determined in central venous and 
portal venous blood were signifi cantly diminished by 
IPC. 
 Parameters of Hepatocellular Injury and Function 
 No preoperative signifi cant differences in serum ac-
tivities (IU) were observed between groups with respect 
to alanine transferase (ALT: range 21.5–32.7) or aspar-
tate transferase (AST: range 15.0–22.7). When the Prin-
gle maneuver was applied (group II), ALT and AST were 
signifi cantly (p  ! 0.05) elevated as compared with the 
non-Pringle group (group I) on the fi rst and second post-
Group I Group II Group III
Inosine, nmol/l
Pre resection 7.1987.52 –8.80811.14 – 28.0810.2
3 min after resection/reperfusion 71.00859.0 279.08267 – 5822.0
15 min after resection/reperfusion 4.487.6 –10.3817.0 – 16.985.8
Hypoxanthine, mol/l
Pre resection 0.2880.038 –0.0380.25 –0.10880.13
3 min after resection/reperfusion –0.08380.11 0.99880.36§ –0.44580.5
15 min after resection/reperfusion 0.24480.1 0.291854 –0.11780.16
Xanthine, mol/l
Pre resection –0.0280.005 –0.0780.01 –0.0380.009
3 min after resection/reperfusion –0.0980.053 –0.0680.028 –0.15780.096
15 min after resection/reperfusion –0.0480.028 –1.4780.78 –0.0380.014
Means 8 SEM, n = 14–19. § p < 0.05 vs. group III. For further explanations, see legend 
to fi gure 2.
Table 1. Portal venous minus arterial 
 plasma concentration differences of 
 inosine, hypoxanthine and xanthine
Group I Group II Group III
Lactate (mmol/l) central venous
Pre resection 1.1880.11 1.2080.11 1.580.10 $
3 min 1.4380.17* 2.4780.22*, # 2.3380.14*, #
15 min 1.3880.17* 2.2780.23*, # 1.9780.16*, #
30 min 1.3580.20* 2.1280.22* 1.9580.17*, #
2 h 1.6580.166* 2.3380.28*, # 1.9780.16*, #
3 min minus Pre values 0.2980.10 1.2780.17# 0.8280.11*, $
Lactate (mmol/l) portal venous
Pre resection 1.1480.11 1.2080.11 1.4480.10
3 min 1.5280.18* 2.6880.27*, # 2.2780.14*, #
15 min 1.3880.19* 2.1780.24*, # 1.9780.17*, #
30 min 1.4180.13* 2.1480.27*, # 1.8880.22*, #
3 min minus Pre values 0.3480.12 1.5480.24# 0.8680.13#, $
Means 8 SEM, n = 25, * p < 0.05 vs. Pre resection or Pringle, Friedman and post-hoc 
Wilcoxon test; # p < 0.05 vs. group I, $ p < 0.05 vs. group II, Kruskal-Wallis and post-hoc 
Mann-Whitney test.
Table 2. Lactate plasma concentrations 
(mmol/l)
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operative     days     (POD1     and     POD2)    (POD1:    ALT:  
group I: 254.3  8 62.4 vs. group II: 519.4  8 91, and AST: 
group I: 166  8 27 vs. group II: 420  8 104; POD2: ALT: 
group I: 195.8  8 21 vs. group II: 497  8 145 and AST: 
group I: 88  8 21 vs. group II: 246  8 67). When IPC was 
applied (group III), the Pringle maneuver-induced rise of 
serum ALT and AST activities was signifi cantly attenu-
ated only for ALT on the second postoperative day as 
compared with group II (group III: ALT: POD1: 261.4  8 
40.9; POD 2: 208.5  8 36.5 (p  ! 0.05 vs. group II) and 
AST: POD 1: 226.4  8 3.4; POD 2: 105  8 16). 
 In comparison to control group I, the Pringle maneu-
ver also signifi cantly increased postoperative total serum 
bilirubin concentrations and decreased thromboplastin 
times and serum factor V activities. These Pringle ma-
neuver-associated disturbances in liver secretory func-
tion and protein synthesis, however, were not signifi cant-
ly attenuated by IPC (data not shown). 
 Discussion 
 Role of Adenosine in Hepatic Preconditioning 
 Ischemia has for a long time been known to cause the 
degradation of adenine nucleotides leading to the en-
hanced formation of adenosine and its metabolites ino-
sine, hypoxanthine and xanthine. More recently, forma-
tion of adenosine during ischemia has regained attention, 
because this nucleoside is suggested to be a central me-
diator of protection in IPC  [9] . With respect to the liver, 
adenosine has been shown in many animal models to 
protect from tissue injury induced by cold  [2] as well as 
warm ischemia  [1] . Specifi cally, modulation of tissue 
 adenosine by exogenous application  [1] or by increasing 
its endogenous concentrations  [10] were shown to be as 
protective as IPC to prevent from ischemia-reperfusion 
injury. Moreover, activation or antagonism of A 2  recep-
tors by specifi c agonists  [11] and antagonists  [3] mim-
icked or abrogated the protection of the liver afforded by 
IPC, respectively. In humans, recent studies provided 
also good evidence for adenosine to exert some of the 
protective effects of IPC, although these observations 
were limited to the heart  [12, 13] . There is also increasing 
evidence for protective effects of IPC in major liver resec-
tion as suggested by signifi cantly reduced hepatocellular 
injury  [14–16] and improved intraoperative hemody-
namic stability. Additionally, IPC not only allowed to 
attenuate ischemic liver injury but to also take advantage 
of the Pringle maneuver to reduce blood loss during re-
section by up to   65%  [15] . However, the role of adeno-
sine in hepatic preconditioning was not considered so far. 
Thus, in the present study we tested (i) whether adenosine 
plasma concentrations were transiently increased by IPC 
and (ii) whether the Pringle maneuver-induced elevations 
of plasma purines could be attenuated by IPC. 
 As shown in  fi gure 2, plasma concentrations of adeno-
sine were increased during the early phase of reperfusion 
in portal venous blood. However, this rise in adenosine 
was not signifi cant statistically but was paralleled by sig-
nifi cant increases of its major metabolites inosine, hypo-
xanthine and xanthine, indicating that substantial forma-
tion of adenosine had taken place ( fi g. 1, 2 ). 
 Enhanced formation of adenosine’s degradation prod-
ucts due to hepatic preconditioning is in agreement with 
depletion of ATP, adenosine diphosphate (ADP), 
 adenosine monophosphate (AMP) and accumulation of 
adenosine, inosine, hypoxanthine, and xanthine within 
10 min of warm liver ischemia  [11, 17, 18] . Of course, the 
demonstration of a signifi cant rise in portal venous plas-
ma concentrations of adenosine’s degradation products 
is no defi nite proof for adenosine being a central media-
tor in hepatic preconditioning. To this end, pharmaco-
logic preconditioning of the human liver by transient in-
travenous infusion of adenosine would appear to be a 
more appropriate tool to address this question under clin-
ical conditions. 
 Effects of IPC on Plasma Metabolites Refl ecting 
Severity of Tissue Ischemia 
 Currently, there is little doubt on the protective po-
tency of IPC for the liver. In many animal models of 
warm liver injury, ischemic preconditiong was not only 
effective to attenuate cell damage but also to better pre-
serve those cell functions known to be dependent on the 
availability of ATP. Among these, secretion of bile is a 
process which is quite sensitive to a lack in cellular en-
ergy. In fact, in animal models, IPC improved post-isch-
emic bile excretion  [19] . Moreover, several investigators 
demonstrated that ischemic or pharmacologic precondi-
tioning (use of A 2  receptor agonists) decreases the loss in 
tissue levels of ATP and ADP during a subsequent more 
severe ischemic period  [11, 18] . In these studies, the IPC-
mediated preservation of adenine nucleotides was also 
refl ected by a reduction of inosine, hypoxanthine and 
xanthine accumulation, respectively  [18] . Formation of 
lactate was also diminished. Similar observations have 
been reported from animal models of myocardial precon-
ditioning, suggesting tissue protection by preconditioning 
through preservation of ATP stores and reducing lactate 
accumulation  [20] . In agreement with these observations 
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in animal models, patients subjected to IPC showed low-
er plasma concentrations of inosine, hypoxanthine and 
xanthine after the Pringle maneuver than patients with-
out preconditioning ( fi g. 3 ). In parallel, the rise in the 
plasma concentrations of lactate was also attenuated by 
IPC ( table 2 ). However, signifi cant reduction of purines 
by IPC could be only observed in portal venous blood for 
inosine and hypoxanthine. In consideration of the less 
pronounced effects detected in central venous blood, it 
should be taken into account that relatively high concen-
trations of purines leaving the liver during early reperfu-
sion were likely to be diluted with purine-poor venous 
blood returning from the lower and upper caval vein be-
fore being collected from the central venous line. Despite 
these limitations, amelioration of plasma purine metabo-
lites and lactate in preconditioned patients may yet indi-
cate preservation of cellular energy homeostasis as al-
ready shown in various animal models  [11, 18, 20] . In 
these studies, more detailed analyses of biochemical path-
ways led to the conclusion of induction of ‘metabolic ar-
rest’ in terms of less ATP depletion and lactate accumula-
tion as a possible mechanism by which IPC protects tis-
sues during ischemia  [18] . Very recently, Clavien et al. 
 [21] published a prospective randomized clinical study in 
which they confi rmed their own previously described pro-
tective effect of IPC in patients undergoing major liver 
resection under infl ow occlusion. Although adenine nu-
cleotides were analyzed in liver tissue samples that were 
not taken by in situ freeze clampage, Clavien et al. showed 
exemplarily with 5 patients per group a statistically sig-
nifi cant higher post-ischemic hepatic ATP content in pa-
tients that were pretreated by IPC. 
 Role of the Intestine in Hepatic Preconditioning 
 Because we were not able for ethical and technical rea-
sons to perform direct measurements of tissue concentra-
tions of purines and lactate, we determined plasma con-
centrations of energy-dependent metabolites at different 
sampling sites in order to calculate concentration differ-
ences across vascular beds. Surprisingly, portal venous 
concentrations of purines signifi cantly increased in re-
sponse to the Pringle maneuver. Even more important, 
this increase was signifi cantly attenuated by IPC. More-
over, when the difference between plasma concentrations 
of purines between portal venous blood and arterial blood 
was calculated, a positive difference was obtained for pa-
tients who underwent the Pringle maneuver without pre-
conditioning ( table 1 ). In contrast, in patients with pre-
conditioning, the corresponding calculated difference 
leveled around zero. These results suggest that clamping 
of the portal triad, i.e. occlusion of the venous outfl ow of 
the intestine, causes severe congestion of the nutritive 
blood fl ow which leads to the net production of purine 
metabolites. Thus, not only the liver but also the intestine 
was obviously subjected to compromises of its energy me-
tabolism by the Pringle maneuver and the associated net 
production of purines in the intestine could be prevented 
by IPC. IPC might, hence, protect not only the liver but 
also the intestine from ischemic injury. To further sub-
stantiate this conclusion, one wishes to have determined 
tissue concentrations of purines or other parameters of 
intestine lesions. Taking biopsies of the intestinal wall, 
however, represents an unacceptable risk for severe intra-
abdominal infectious complications due to possible sec-
ondary bowel perforation. 
 Clinical Model and Effi cacy of IPC 
 In the present study, patients were enrolled in a pro-
spective manner and duration of the Pringle maneuver 
was adapted to surgical requirements. Accordingly, the 
results were obtained under clinical conditions of routine 
surgery with unavoidable variations of ischemia (Pringle) 
times. Despite the heterogeneity of the duration of the 
Pringle maneuver, IPC appeared to be effective in at-
tenuating hepatocellular injury as assessed by the postop-
erative serum liver transferase activities (see Results and 
Choukèr et al.  [16] ). 
 In conclusion, the results of this prospectively ran-
domized clinical study demonstrate that IPC very likely 
enhances formation of adenosine as refl ected by increased 
central and portal venous plasma concentrations of 
 adenosine’s degradation products inosine, hypoxanthine 
and xanthine. In addition, IPC attenuates disturbances 
in the hepatic energy metabolism caused by a subsequent 
more severe ischemic period as suggested by the decreased 
plasma concentrations of purines following the Pringle 
maneuver. In agreement with results from animal models 
suggesting a ‘metabolic arrest’, IPC diminished plasma 
lactate concentrations during reperfusion in humans as 
well. Most interestingly, IPC also decreased formation of 
purines in the intestine. Thus, protection of the human 
liver from ischemic tissue injury may not only be afford-
ed by direct adaptive metabolic effects within the liver, 
but might result also from preconditioning of the intes-
tine. 
 Choukèr /Martignoni /Schauer /Rau /Volk /
Heizmann /Dugas /Messmer /Peter /Thiel 
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